Boston Scientific : Receives FDA Approval of Spinal Cord Stimulation Therapy for People Living with Diabetic Peripheral Neuropathy -October 11, 2023 at 08:25 am EDT : vimarsana.com

MARLBOROUGH, Mass., Oct. 11, 2023 -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved an expanded indication of the WaveWriter Alpha™...

Related Keywords

United States , Boston , Massachusetts , American , Americans , Jessica Sachariason , Lauren Tengler , Wavewriter Alpha , Jim Cassidy , Exchange Commission , Drug Administration , Boston Scientific , Boston Scientific Corporation , American Diabetes Association , Twitter , Facebook , Securities Exchange , Scientific Corporation , Spinal Cord Stimulator , Boston Scientific Chronic Pain , Fast Acting Sub Perception Therapy , Radiofrequency Ablation , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Body Guidelines , Wavewriter Alpha Prime Spinal Cord Stimulator , Indirect Decompression , Markets ,